Inhibitory effects of wogonin on catalytic activity of cytochrome P450 enzyme in human liver microsomes

[1]  H. Kwon,et al.  Wogonin induces differentiation and neurite outgrowth of neural precursor cells. , 2010, Biochemical and biophysical research communications.

[2]  Z. Ismail,et al.  In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica. , 2010, Journal of ethnopharmacology.

[3]  B. Shim,et al.  Anti-inflammatory effects of Scutellaria baicalensis extract via suppression of immune modulators and MAP kinase signaling molecules. , 2009, Journal of ethnopharmacology.

[4]  Wei Duan,et al.  Insights into the structure, function, and regulation of human cytochrome P450 1A2. , 2009, Current drug metabolism.

[5]  L. Wallentin.  P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. , 2009, European heart journal.

[6]  L. Walker,et al.  Alkaloids and saponins as cytochrome P450 inhibitors from blue cohosh (Caulophyllum thalictroides) in an in vitro assay. , 2009, Planta medica.

[7]  Hee-Sun Kim,et al.  Wogonin inhibits microglial cell migration via suppression of nuclear factor-kappa B activity. , 2008, International immunopharmacology.

[8]  Paavo Honkakoski,et al.  Inhibition and induction of human cytochrome P450 enzymes: current status , 2008, Archives of Toxicology.

[9]  Kiyomi Ito,et al.  Effects of Kampo medicines on CYP and P-gp activity in vitro. , 2008, Biological & pharmaceutical bulletin.

[10]  Yong Yang,et al.  Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2. , 2008, Life sciences.

[11]  Guang-Ji Wang,et al.  Gender difference regarding schizandrin pharmacokinetics in rats , 2008, European Journal of Drug Metabolism and Pharmacokinetics.

[12]  J. Cheong,et al.  Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. , 2007, European journal of pharmacology.

[13]  A. Kalgutkar,et al.  Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions. , 2007, Current drug metabolism.

[14]  E. Hodgson,et al.  The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals. , 2007, Pharmacology & therapeutics.

[15]  Yong Yang,et al.  The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo. , 2006, Biological & pharmaceutical bulletin.

[16]  H. Iwata,et al.  CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[17]  P. Saxena,et al.  Protection against aflatoxin-B1-induced liver mutagenesis by Scutellaria baicalensis. , 2005, Mutation research.

[18]  A. Li,et al.  An evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytes. , 2004, Chemico-biological interactions.

[19]  Terry A Jacobson,et al.  Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. , 2004, The American journal of cardiology.

[20]  T. Edeki,et al.  The Inhibitory Effects of Herbal Components on CYP2C9 and CYP3A4 Catalytic Activities in Human Liver Microsomes , 2004, American journal of therapeutics.

[21]  S. Ishida,et al.  Effects of Sho-saiko-to extract and its components, Baicalin, baicalein, glycyrrhizin and glycyrrhetic acid, on pharmacokinetic behavior of salicylamide in carbon tetrachloride intoxicated rats. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[22]  Honghao Zhou,et al.  St John's wort induces both cytochrome P450 3A4–catalyzed sulfoxidation and 2C19–dependent hydroxylation of omeprazole , 2004, Clinical pharmacology and therapeutics.

[23]  F. Lakehal,et al.  Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19 , 2002, Epilepsy Research.

[24]  G. Caldwell,et al.  Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. , 2001, Current topics in medicinal chemistry.

[25]  R. Park,et al.  Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B1 oxidizing cytochrome P450 enzymes. , 2001, Planta medica.

[26]  H. Young,et al.  The flavonoid baicalin inhibits superantigen‐induced inflammatory cytokines and chemokines , 2001, FEBS letters.

[27]  Ling-Ling Yang,et al.  Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. , 2001, Biochemical pharmacology.

[28]  Y. L. Lin,et al.  Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice. , 2000, Life sciences.

[29]  J. Taylor,et al.  Probable Antagonism of Warfarin by Green Tea , 1999, The Annals of pharmacotherapy.

[30]  H. Welker,et al.  Clinical Pharmacokinetics of Mibefradil , 1998, Clinical pharmacokinetics.

[31]  J. Ward,et al.  Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. J. Zielinski,et al.  Dual Effects of Carbamazepine‐Phenytoin Interaction , 1987, Therapeutic drug monitoring.

[33]  W. Kalow,et al.  Mephenytoin and sparteine pharmacogenetics in Canadian Caucasians , 1984, Clinical pharmacology and therapeutics.

[34]  L. Xiao-dong,et al.  The influence of a newly developed quinolone: Antoflox-acin, on CYP activity in rats , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[35]  Y. Aso,et al.  In vivo approach for the evaluation of mechanism-based inhibition of cytochrome P450 3A in rats. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[36]  R. Preisig,et al.  Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man , 2004, European Journal of Clinical Pharmacology.

[37]  G. Flesch.  Overview of the Clinical Pharmacokinetics of Oxcarbazepine , 2004, Clinical drug investigation.

[38]  E Sasaki,et al.  Comparative study of oral and parenteral administration of sho-saiko-to (xiao-chaihu-tang) extract on D-galactosamine-induced liver injury in rats. , 1997, The American journal of Chinese medicine.

[39]  M. Kuo,et al.  Modulation of microsomal cytochrome P450 by Scutellariae Radix and Gentianae scabrae Radix in rat liver. , 1996, The American journal of Chinese medicine.